The 4 key things we’re watching in the stock market this holiday-shortened week

[ad_1] The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new…

Here are 9 stocks that can benefit from Fed interest rate cuts

[ad_1] The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected…

Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks

[ad_1] Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing…

Jim Cramer says Nike should watch its back with Hoka running shoes doing so well

[ad_1] CNBC’s Jim Cramer sees footwear company Deckers Outdoor as a disruptive industry player that even…

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Here are the portfolio’s top 5 performers in a record-setting week for stocks

[ad_1] The bulls got what they wanted this week: cooler inflation data and record highs. The…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

[ad_1] Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea —…

Abbott Labs’ surprise guidance bump is a major positive for its shareholders

[ad_1] Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe…

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

[ad_1] Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this…

Here are the 8 trades and 3 price-target changes we made during a busy week

[ad_1] Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly…

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

[ad_1] The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to…

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

Here’s what is behind the stock market’s sell-off and what we’re doing about it

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…